Health and Welfare Committee urged to expand bio-equivalent tests.

The Health and Welfare Committee of the National Assembly discussed current issues in the KFDA's report meeting on June 22 especially over the bio-equivalent tests, the drug safety measure, the food safety and control system and the earlier health registration of orphan drugs like Gleevec capsule.

The Committee pointed out that the bio-equivalent tests might get flimsy if its test period be ...